comparemela.com

FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen's Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials

FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen's Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China ,Japan ,David Delucia ,Deyaa Adib ,Simon Miller ,Globenewswire Inc ,Corporate Communications ,Fibrogen Inc ,Exchange Commission ,Drug Administration ,Regeneron Pharmaceuticals ,Nasdaq ,China Health Authority ,Chief Medical Officer ,Investigational New Drug ,Supplemental New Drug Application ,Investor Inquiries ,Investor Relations ,Media Inquiries ,

comparemela.com © 2020. All Rights Reserved.